MarketInOut Stock Screener Log In | Sign Up
 

Tempus AI Inc

NASDAQ • Healthcare • Health Information Services • Quote as of 05/08/2026
Tempus AI Inc stock price and volume chart

Company Profile

IndustryHealth Information Services
SectorHealthcare
ExchangeNASDAQ
Market Capitalization8,923.47 mln
Float114 mln
Earnings Date08/11/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-1.25
Manipulation likely

1-Year Forecast

69.27
Strong upside

Relative Strength

18 / 100
Significantly lagging

Debt / Equity

3.17
Highly leveraged

ROE

-73.83
Deeply negative

Business Description

Tempus AI Inc. is a Chicago-based healthcare technology company that uses artificial intelligence and advanced diagnostics to help doctors make better treatment decisions for their patients. The company collects and analyzes genetic, clinical, and imaging data through its suite of tools, giving physicians, researchers, and life sciences companies deeper insight into diseases ranging from cancer to psychiatric conditions. Tempus also helps match patients to clinical trials and partners with major pharmaceutical companies, including AstraZeneca, GSK, and Merck, to advance precision medicine research.

Key Fundamentals

EPS-1.72
ROE-73.83
RPS7.73
ROIC-21.00
ROA-15.36
EBITDA, mln-127
EV / EBITDA-70.82
EV / EBIT-38.24
Revenue, mln1,364
EV / Revenue6.59

Financial Strength

Altman Z-Score2.5
Piotroski F-Score 5 / 9
Beneish M-Score-1.25
1-Year Target Price69.27
Short Ratio5.51
Short % of Float28.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -9.35% 8 / 100   
1 Month 12.91% 79 / 100   
2 Months -16.65% 19 / 100   
6 Months -39.39% 15 / 100   
1 Year -15.15% 22 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us